Atlas Trials

Carbamazepine in Severe Liver Disease Due to Alpha-1 Antitrypsin Deficiency

Clinical trial NCT01379469 · TERMINATED

Trial details

NCT number
NCT01379469
Sponsor
Washington University School of Medicine
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Alpha-1-antitrypsin DeficiencyLiver Cirrhosis
Start date
2012-01-01
Primary completion
2017-02-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.